Cargando…
Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc. on behalf of the AGA Institute.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073076/ https://www.ncbi.nlm.nih.gov/pubmed/37360678 http://dx.doi.org/10.1016/j.gastha.2023.03.025 |
_version_ | 1785019512926502912 |
---|---|
author | Hughes, Robert M. Frey, Sarah Teles, Mayan Connolly, Caoilfhionn M. Segev, Dorry L. Werbel, William A. Chen, Po-Hung |
author_facet | Hughes, Robert M. Frey, Sarah Teles, Mayan Connolly, Caoilfhionn M. Segev, Dorry L. Werbel, William A. Chen, Po-Hung |
author_sort | Hughes, Robert M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10073076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Published by Elsevier Inc. on behalf of the AGA Institute. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100730762023-04-05 Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis Hughes, Robert M. Frey, Sarah Teles, Mayan Connolly, Caoilfhionn M. Segev, Dorry L. Werbel, William A. Chen, Po-Hung Gastro Hep Adv Research Letter Published by Elsevier Inc. on behalf of the AGA Institute. 2023-04-05 /pmc/articles/PMC10073076/ /pubmed/37360678 http://dx.doi.org/10.1016/j.gastha.2023.03.025 Text en © 2023 Published by Elsevier Inc. on behalf of the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Research Letter Hughes, Robert M. Frey, Sarah Teles, Mayan Connolly, Caoilfhionn M. Segev, Dorry L. Werbel, William A. Chen, Po-Hung Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis |
title | Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis |
title_full | Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis |
title_fullStr | Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis |
title_full_unstemmed | Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis |
title_short | Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis |
title_sort | durability of antibody response six months after two-dose sars-cov-2 mrna vaccination in patients with cirrhosis |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073076/ https://www.ncbi.nlm.nih.gov/pubmed/37360678 http://dx.doi.org/10.1016/j.gastha.2023.03.025 |
work_keys_str_mv | AT hughesrobertm durabilityofantibodyresponsesixmonthsaftertwodosesarscov2mrnavaccinationinpatientswithcirrhosis AT freysarah durabilityofantibodyresponsesixmonthsaftertwodosesarscov2mrnavaccinationinpatientswithcirrhosis AT telesmayan durabilityofantibodyresponsesixmonthsaftertwodosesarscov2mrnavaccinationinpatientswithcirrhosis AT connollycaoilfhionnm durabilityofantibodyresponsesixmonthsaftertwodosesarscov2mrnavaccinationinpatientswithcirrhosis AT segevdorryl durabilityofantibodyresponsesixmonthsaftertwodosesarscov2mrnavaccinationinpatientswithcirrhosis AT werbelwilliama durabilityofantibodyresponsesixmonthsaftertwodosesarscov2mrnavaccinationinpatientswithcirrhosis AT chenpohung durabilityofantibodyresponsesixmonthsaftertwodosesarscov2mrnavaccinationinpatientswithcirrhosis |